Topical treatment against adenoviral infection

Organization:University of Pittsburgh, Pa, US
I.P. Brief:The inventors have discovered a new use for the compound Iv-IgG. When administered topically, this drug is effective in the treatment of Epidemic Keratoconjunctivis (EKC). Used opthalmically, these preparations have demonstrated the elimination of the infection, reduction of viral shedding and a decreased transmission of the virus.
Keywords:therapeutic , anti-viral, keratoconjuncitivits, opthalmic
Primary Industry:Pharma & Biotech
Specific Market:drug companies focused on infectious diseases

Full IP Descriptions available on-site.


Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor

University of Hawaii

Press Sponsor

Business Wire

Commercialization Partner



Invest Australia AzTE Technology Enterprises

Media Sponsors

(joint with Nanotech 2007) Nature
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network


“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
Matthew Laudon, Co-Founder and Director of TechConnect